glucagen novo injektionspräparat
novo nordisk pharma ag - glucagonum adnr - injektionspräparat - praeparatio cryodesiccata: glucagonum adnr 1 mg ut glucagoni hydrochloridum adnr, lactosum monohydricum, acidum hydrochloricum q.s. ad ph, natrii hydroxidum q.s. ad ph pro vitro. solvens: aqua ad iniectabile 1 ml. - insulina l'ipoglicemia; immobilizzazione del intestinaltraktes in endoscopia e le radiografie - biotechnologika
glucagen
novo nordisk a/s - glucagone - glucagone
baqsimi
eli lilly nederland b.v. - glucagone - diabete mellito - ormoni pancreatici, glycogenolytic ormoni - baqsimi è indicato per il trattamento di ipoglicemia grave negli adulti, adolescenti e bambini di età compresa tra i 4 anni e oltre con diabete mellito.
baqsimi 3 mg poudre nasale
eli lilly (suisse) sa - glucagonum - poudre nasale - glucagonum 3 mg, betadexum, dodecylphosphocholinum, ad pulverem. - hypoglycémie sévère - synthetika
ogluo
tetris pharma b.v - glucagone - diabete mellito - ormoni pancreatici, glycogenolytic ormoni - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
glucagone novo
novo nordisk a/s - ormoni glicogenolitici - ormoni glicogenolitici
galvus
novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).
xiliarx
novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).